Clinical Trial Update: A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of Golimumab in active rheumatoid arthritis patients previously treated with anti-TNF biologics; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED | Results posted: 2011-09-28